Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket

Loading...
Loading...

Gainers

  • Troika Media Group Inc TRKA shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.
  • Owlet Inc OWLT rose 45.3% to $0.50 in pre-market trading after reporting a $30 million private placement financing.
  • Sigma Lithium Corp SGML rose 26.7% to $37.35 in pre-market trading. Sigma Lithium, during January, filed NI 43-101 technical report for production expansion supporting the previously announced 60% increase in
  • mineral reserves and $15.3 billion NPV.
  • Arbe Robotics Ltd ARBE rose 19.5% to $5.20 in pre-market trading after gaining 12% on Friday.
  • Actinium Pharmaceuticals Inc ATNM rose 18% to $16.24 in pre-market trading. Actinium recently signed a cooperative research and development agreement with National Cancer Institute to further enhance clinical and non-clinical development of actimab-A for the treatment of acute myeloid leukemia and other hematologic malignancies.
  • Apellis Pharmaceuticals Inc APLS shares rose 13.4% to $62.99 in pre-market trading after the company said that the FDA approved SYFOVRE as first and only treatment for geographic atrophy.
  • Connexa Sports Technologies Inc CNXA rose 11.7% to $0.27 in pre-market trading.
  • Aurora Mobile Ltd - ADR JG shares rose 10.3% to $0.75 in pre-market trading. Aurora Mobile recently partnered with Shengshi Dalian Automobile to explore automobile butler service market.
  • MDxHealth SA - ADR MDXH rose 9.2% to $4.29 in pre-market trading. The company, last month, reaffirmed FY23 sales guidance of $65 million to $70 million.
  • Zedge, Inc. ZDGE rose 7% to $2.89 in pre-market trading. Zedge, during December, posted a Q1 loss of $0.01 per share.

Losers

  • iBio, Inc. IBIO shares fell 13.5% to $1.28 in pre-market trading. iBio shares jumped over 97% on Friday after the company announced MUC16 as its latest immune-oncology target program.
  • Vinco Ventures, Inc. BBIG shares dropped 11.4% to $0.5110 in pre-market trading. VVIP Ventures recently entered into an Asset Purchase Agreement with magazine publisher a360 Media to acquire the National Enquirer, the National Examiner and Globe. VVIP Ventures is a joint venture between Vinco Ventures and ICON Publishing, LLC.
  • Vallon Pharmaceuticals, Inc. VLON fell 10% to $0.7140 in pre-market trading after climbing over 10% on Friday.
  • Sorrento Therapeutics, Inc. SRNE fell 9.7% to $0.2799 in pre-market trading after jumping 20% on Friday.
  • JD.com, Inc. JD fell 8.1% to $48.72 in pre-market following a media report that the company is planning a $1.5 billion subsidy campaign to compete against rivals.
  • OKYO Pharma Limited OKYO fell 7.7% to $3.45 in pre-market trading after surging 58% on Friday. OKYO Pharma, during December, announced U.S. FDA clearance of IND application for OK-101 for the treatment of dry eye disease.
  • GeneDx Holdings Corp. WGS fell 7.7% to $0.48 in pre-market trading.
  • EBET, Inc. EBET fell 6.4% to $0.55 in pre-market trading. EBET shares gained over 10% on Friday following strong Q4 results and guidance from DraftKings.
  • SciSparc Ltd. SPRC fell 5.5% to $0.9452 in pre-market trading. SciSparc shares gained around 10% on Friday after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement.
  • NexImmune, Inc. NEXI shares fell 5.1% to $0.5599 in pre-market trading. NexImmune recently announced data showing AIM ACT T cells enhance the response to bispecific T cell engager therapy at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

Now Read This: Fear & Greed Index Remains In 'Greed' Zone After Dow Gains Over 100 Points

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...